↓ Skip to main content

Exosomes in Cardiovascular Diseases

Overview of attention for book
Cover of 'Exosomes in Cardiovascular Diseases'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Multifaceted Functions of Exosomes in Health and Disease: An Overview
  3. Altmetric Badge
    Chapter 2 Exosomes: Nanocarriers of Biological Messages
  4. Altmetric Badge
    Chapter 3 Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis
  5. Altmetric Badge
    Chapter 4 Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases
  6. Altmetric Badge
    Chapter 5 Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases
  7. Altmetric Badge
    Chapter 6 Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy
  8. Altmetric Badge
    Chapter 7 Dual Behavior of Exosomes in Septic Cardiomyopathy
  9. Altmetric Badge
    Chapter 8 Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy
  10. Altmetric Badge
    Chapter 9 Peripartum Cardiomyopathy: Do Exosomes Play a Role?
  11. Altmetric Badge
    Chapter 10 Vascular Calcification Regulation by Exosomes in the Vascular Wall
  12. Altmetric Badge
    Chapter 11 Cardioprotective Effects of Exosomes and Their Potential Therapeutic Use
  13. Altmetric Badge
    Chapter 12 Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease
  14. Altmetric Badge
    Chapter 13 Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases
  15. Altmetric Badge
    Chapter 14 Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair
  16. Altmetric Badge
    Chapter 15 Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease
  17. Altmetric Badge
    Chapter 16 Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology
  18. Altmetric Badge
    Chapter 17 Circulating Exosomes in Cardiovascular Diseases
  19. Altmetric Badge
    Chapter 18 Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases
  20. Altmetric Badge
    Chapter 19 Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy
Attention for Chapter 12: Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease
Chapter number 12
Book title
Exosomes in Cardiovascular Diseases
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/978-981-10-4397-0_12
Pubmed ID
Book ISBNs
978-9-81-104396-3, 978-9-81-104397-0
Authors

Etsu Suzuki, Daishi Fujita, Masao Takahashi, Shigeyoshi Oba, Hiroaki Nishimatsu

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells that reside in various organs. They have the capacity to differentiate into various cell types, including cardiomyocytes, vascular endothelial cells, and vascular smooth muscle cells. Among the various MSCs, bone marrow-derived MSCs (BMMSCs) have been widely used for treating acute myocardial infarction (AMI) and ischemic heart failure (IHF) in preclinical and clinical studies. Although the beneficial effects of BMMSCs in treating AMI and IHF were originally attributed to their capacity to differentiate into cardiac cell types, recent evidence suggests that the differentiation capacity of BMMSCs appears to be minimal and that BMMSCs exert cardioprotective effects by secreting paracrine factors. In this context, MSC-derived exosomes have recently gained much attention. In this chapter, we introduce preclinical studies in which MSC-derived exosomes are used for treating cardiovascular diseases (CVDs) such as AMI, stroke, pulmonary hypertension, and septic cardiomyopathy. Future clinical studies are required to confirm the efficacy of exosome administration in treating CVDs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 14%
Researcher 9 12%
Student > Bachelor 8 11%
Student > Doctoral Student 7 9%
Student > Master 6 8%
Other 10 13%
Unknown 25 33%
Readers by discipline Count As %
Medicine and Dentistry 16 21%
Biochemistry, Genetics and Molecular Biology 11 14%
Agricultural and Biological Sciences 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Engineering 3 4%
Other 9 12%
Unknown 27 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2017.
All research outputs
#13,575,167
of 23,411,993 outputs
Outputs from Advances in experimental medicine and biology
#1,862
of 5,022 outputs
Outputs of similar age
#209,571
of 423,246 outputs
Outputs of similar age from Advances in experimental medicine and biology
#160
of 490 outputs
Altmetric has tracked 23,411,993 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,022 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,246 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 490 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.